Dr. Lane Frey, M.D
NPI: 1932337052
Total Payments
$201,502
2024 Payments
$6,737
Companies
40
Transactions
713
Medicare Patients
2,919
Medicare Billing
$349,695
Payment Breakdown by Category
Other$173,187 (85.9%)
Food & Beverage$11,860 (5.9%)
Travel$9,392 (4.7%)
Consulting$6,988 (3.5%)
Education$76.21 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $173,187 | 96 | 85.9% |
| Food and Beverage | $11,860 | 533 | 5.9% |
| Travel and Lodging | $9,392 | 71 | 4.7% |
| Consulting Fee | $6,988 | 6 | 3.5% |
| Education | $76.21 | 7 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $138,109 | 288 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $46,132 | 94 | $0 (2023) |
| Lilly USA, LLC | $12,805 | 93 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $833.46 | 29 | $0 (2023) |
| SANOFI-AVENTIS U.S. LLC | $491.08 | 29 | $0 (2024) |
| Abbott Laboratories | $445.95 | 24 | $0 (2024) |
| Dexcom, Inc. | $315.50 | 17 | $0 (2024) |
| Amgen Inc. | $245.61 | 12 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $182.50 | 10 | $0 (2024) |
| Corcept Therapeutics | $177.01 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,737 | 53 | Novo Nordisk Inc ($6,017) |
| 2023 | $12,304 | 65 | Novo Nordisk Inc ($10,326) |
| 2022 | $48,864 | 109 | Novo Nordisk Inc ($40,280) |
| 2021 | $23,422 | 72 | Novo Nordisk Inc ($19,968) |
| 2020 | $44,433 | 80 | Novo Nordisk Inc ($36,060) |
| 2019 | $37,486 | 118 | Novo Nordisk Inc ($25,030) |
| 2018 | $14,837 | 111 | Boehringer Ingelheim Pharmaceuticals, Inc. ($13,005) |
| 2017 | $13,419 | 105 | Boehringer Ingelheim Pharmaceuticals, Inc. ($8,950) |
All Payment Transactions
713 individual payment records from CMS Open Payments — Page 1 of 29
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/26/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $22.02 | General |
| Category: Automated insulin delivery system | ||||||
| 12/18/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $17.25 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: Endocrinology | ||||||
| 12/11/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $23.47 | General |
| Category: Bone Health | ||||||
| 12/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.91 | General |
| Category: Diabetes | ||||||
| 12/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $11.82 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $27.77 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.39 | General |
| Category: Cardio-renal | ||||||
| 11/06/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: Diabetes | ||||||
| 10/30/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $20.95 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 10/23/2024 | RECORDATI_RARE_DISEASES_INC. | SIGNIFOR LAR (Drug), ISTURISA | Food and Beverage | In-kind items and services | $22.96 | General |
| Category: ENDOCRINE AGENT | ||||||
| 10/09/2024 | Lilly USA, LLC | — | Food and Beverage | In-kind items and services | $20.34 | General |
| 10/02/2024 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $22.35 | General |
| Category: Endocrinology | ||||||
| 09/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $15.56 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/18/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 08/28/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $10.64 | General |
| Category: Diabetes | ||||||
| 08/07/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $15.11 | General |
| Category: Durable Pump | ||||||
| 07/31/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $25.51 | General |
| Category: Bone Health | ||||||
| 07/17/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $750.00 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 07/10/2024 | ABBVIE INC. | SYNTHROID (Drug) | Food and Beverage | In-kind items and services | $16.84 | General |
| Category: IMMUNOLOGY | ||||||
| 06/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: Diabetes Care | ||||||
| 06/19/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $23.50 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/12/2024 | CeQur Corporation | CeQur Simplicity (Device) | Food and Beverage | Cash or cash equivalent | $22.04 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 696 | 1,115 | $347,741 | $94,141 |
| 2022 | 7 | 740 | 1,174 | $347,138 | $94,991 |
| 2021 | 7 | 727 | 1,088 | $310,190 | $90,770 |
| 2020 | 10 | 756 | 1,055 | $249,567 | $69,793 |
Total Patients
2,919
Total Services
4,432
Medicare Billing
$349,695
Procedure Codes
29
All Medicare Procedures & Services
29 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 521 | 939 | $290,151 | $77,957 | 26.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 101 | 101 | $41,208 | $11,572 | 28.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 49 | 50 | $10,950 | $2,897 | 26.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 14 | 14 | $4,662 | $1,396 | 29.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 11 | 11 | $770.00 | $318.89 | 41.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 481 | 856 | $265,312 | $71,043 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 98 | 98 | $39,984 | $11,396 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 97 | 105 | $23,026 | $5,912 | 25.7% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 16 | 67 | $11,733 | $3,683 | 31.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 14 | 14 | $4,665 | $1,469 | 31.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 16 | 16 | $1,248 | $1,022 | 81.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 18 | 18 | $1,170 | $466.12 | 39.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 404 | 750 | $231,996 | $66,139 | 28.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 98 | 98 | $39,939 | $12,257 | 30.7% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 124 | 139 | $29,876 | $8,011 | 26.8% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 41 | 41 | $3,227 | $2,606 | 80.8% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 12 | 12 | $3,231 | $1,059 | 32.8% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 36 | 36 | $1,441 | $569.54 | 39.5% |
| 90471 | Administration of 1 vaccine | Office | 2021 | 12 | 12 | $480.00 | $128.50 | 26.8% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 381 | 648 | $163,133 | $44,901 | 27.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 87 | 87 | $34,713 | $9,969 | 28.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 174 | 202 | $33,380 | $9,201 | 27.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 12 | 16 | $5,600 | $1,528 | 27.3% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 24 | 24 | $4,224 | $1,186 | 28.1% |
| 90662 | Vaccine for influenza for injection into muscle | Office | 2020 | 15 | 15 | $1,605 | $902.52 | 56.2% |
About Dr. Lane Frey, M.D
Dr. Lane Frey, M.D is a Student in an Organized Health Care Education/Training Program healthcare provider based in Thibodaux, Louisiana. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/26/2009. The National Provider Identifier (NPI) number assigned to this provider is 1932337052.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lane Frey, M.D has received a total of $201,502 in payments from pharmaceutical and medical device companies, with $6,737 received in 2024. These payments were reported across 713 transactions from 40 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($173,187).
As a Medicare-enrolled provider, Frey has provided services to 2,919 Medicare beneficiaries, totaling 4,432 services with total Medicare billing of $349,695. Data is available for 4 years (2020–2023), covering 29 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Diabetes & Metabolism
- Location Thibodaux, LA
- Active Since 06/26/2009
- Last Updated 07/05/2018
- Taxonomy Code 390200000X
- Entity Type Individual
- NPI Number 1932337052
Products in Payments
- JARDIANCE (Drug) $58,146
- Ozempic (Drug) $41,370
- Rybelsus (Drug) $39,973
- RYBELSUS (Drug) $36,051
- Tresiba (Drug) $13,904
- FARXIGA (Drug) $789.22
- Victoza (Drug) $342.57
- HUMULIN (Drug) $281.00
- Korlym (Drug) $177.01
- TRADJENTA (Drug) $146.38
- FreeStyle Libre (Device) $144.42
- V-GO (Device) $142.65
- SOLIQUA (Drug) $136.74
- TOUJEO (Drug) $133.98
- FreeStyle Libre blood glucose Flash Monitoring System (Device) $120.55
- Kerendia (Drug) $113.51
- INVOKANA (Drug) $110.93
- TRULICITY (Drug) $102.01
- NATPARA (Drug) $101.39
- Prolia (Biological) $94.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Thibodaux
Beau Boudreaux, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $14,300
Student in an Organized Health Care Education/Training Program $14,300
Johnathan Wise, Md, MD
Student in an Organized Health Care Education/Training Program — Payments: $6,516
Student in an Organized Health Care Education/Training Program $6,516
Dr. Tashfin Huq, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $5,934
Student in an Organized Health Care Education/Training Program $5,934
Dr. Elizabeth Mortazavi, D.o, D.O
Student in an Organized Health Care Education/Training Program — Payments: $5,342
Student in an Organized Health Care Education/Training Program $5,342
Dr. Allen Borne, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $4,366
Student in an Organized Health Care Education/Training Program $4,366
Christopher Rodrigue, M.d, M.D
Student in an Organized Health Care Education/Training Program — Payments: $3,814
Student in an Organized Health Care Education/Training Program $3,814